Antipsychotic medicines are a key part of the pharmacological treatment of schizophrenia. Although they provide therapeutic ...

Milsaperidone is an active metabolite of iloperidone ...

Vanda Pharmaceuticals (NASDAQ: VNDA) has secured FDA approval for its new drug, BYSANTI (milsaperidone), marking a significant milestone for the biotech company. The treatment is approved for Bipolar ...

RFK Jr claims keto diet can ‘cure’ schizophrenia - researchers say it may only ease symptoms - Preliminary studies have suggested a keto diet could help improve psychiatric symptoms in people living w ...

Using proprietary copolymer technology, TEV-’749 allows for a controlled steady release of olanzapine, a second generation antipsychotic.

Babies born during Covid could be at increased risk of schizophrenia when they reach adulthood, Britain’s top psychiatrist ...

Most research on autism focuses on younger people, but some studies suggest older adults face increased risks — and perhaps ...

US FDA approves Vanda Pharmaceuticals’ Bysanti to treat bipolar I disorder and schizophrenia: Washington Monday, February 23, 2026, 12:00 Hrs [IST] Vanda Pharmaceuticals Inc., a ...

However, the opioid pathway, a heavily studied physiologic pathway inextricably intertwined with behaviour and reward, rarely receives attention within psychiatric practice. Although the opioid system ...

Each year, the last week of February is recognized as Eating Disorder Awareness Week. In the days leading up to it, my inbox ...

The U.S. Food and Drug Administration has approved milsaperidone (Bysanti) tablets as a first-line therapy for adults with schizophrenia and manic or mixed episodes of bipolar I disorder, ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a first line therapy for the acute treatment ...